[144/A] APi Group Corporation SEC Filing

Rhea-AI Filing Summary

APi Group Corporation filed a Form 144/A reporting a proposed sale of 375,000 shares of common stock through J.P. Morgan Securities LLC on the NYSE with an aggregate market value of $12,922,500. The filing lists 415,888,477 shares outstanding, making the proposed sale approximately 0.09% of outstanding stock.

The filing discloses the acquisition history: 285,000 shares were transferred to JTOO LLC on 10/02/2019, 75,000 shares were transferred to James Lillie and Lisa Sheffield on 10/02/2019, and 15,000 shares were transferred to the Lillie Family Foundation on 10/10/2017; all acquisitions were described as indirectly acquired directly from the issuer. The form reports "Nothing to Report" for securities sold in the past three months and includes the signer’s representation that they are not aware of undisclosed material adverse information.

Positive

• Clear regulatory disclosure of the proposed sale amount, broker, exchange, and aggregate market value
• Sale size is small relative to outstanding shares (~0.09%), limiting likely market impact
• Acquisition history provided, showing transfers and dates that support Rule 144 documentation
• No sales in past three months reported ("Nothing to Report"), reducing immediate signal of concentrated insider selling

Negative

• None.

Insights

Securities Analyst

TL;DR: Small insider sale disclosed; the size is immaterial to capitalization but is a required regulatory disclosure.

The Form 144/A notifies the market of a proposed disposal of 375,000 shares (aggregate value $12.92M) via J.P. Morgan on the NYSE. Relative to 415.9M shares outstanding, this is roughly 0.09%, which is unlikely to move the market by itself. The filing also shows no insider sales in the prior three months, reducing near-term signal risk. From a trading perspective, monitor actual execution details and any clustered insider activity, but this single notice is operationally routine.

Corporate Governance Expert

TL;DR: The filing demonstrates procedural compliance with Rule 144 and documents the chain of acquisition for transparency.

The document records transfers to named entities and individuals with acquisition dates and counts, indicating the filer has documented the origin of the securities as required. The explicit representation that the signer does not possess undisclosed material adverse information is standard but important for compliance. There are no disclosures here of extraordinary arrangements or recent related-party sales; the item appears routine from a governance and disclosure standpoint.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK
Filer CCC
Previous Accession Number Of The Filing
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 390 Madison Avenue, 6th Floor New York NY 10017	375000	12922500	415888477	08/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/02/2019	Transfer to JTOO LLC	Indirectly acquired directly from Issuer			285000	10/02/2019	N/A
Common Stock	10/02/2019	Transfer to James Lillie and Lisa Sheffield	Indirectly acquired directly from Issuer			75000	10/02/2019	N/A
Common Stock	10/10/2017	Transfer to Lillie Family Foundation	Indirectly acquired directly from Issuer			15000	10/10/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Nothing to Report

144/A: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does APG's Form 144/A report?

The filing reports a proposed sale of 375,000 shares of APi Group common stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $12,922,500.

When is the proposed sale scheduled for APG shares?

The form lists the approximate date of sale as 08/11/2025.

How large is the sale relative to APG's outstanding shares?

The filing shows 415,888,477 shares outstanding; 375,000 shares equal approximately 0.09% of the total shares outstanding.

Has the filer sold APG securities in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

What is the acquisition history of the securities to be sold?

Acquisitions listed: 285,000 shares transferred to JTOO LLC on 10/02/2019, 75,000 shares transferred to James Lillie and Lisa Sheffield on 10/02/2019, and 15,000 shares transferred to the Lillie Family Foundation on 10/10/2017.